Skip to main navigation Skip to search Skip to main content

Combination low-intensity chemotherapy plus inotuzumab ozogamicin, blinatumomab and rituximab for pediatric patients with relapsed/refractory B-cell acute lymphoblastic leukemia

Research output: Contribution to journal › Letter › peer-review

Original languageEnglish (US)
Pages (from-to)3042-3047
Number of pages6
JournalHaematologica
Volume109
Issue number9
DOIs
StatePublished - Sep 2024

ASJC Scopus subject areas

  • Hematology

Cite this